Lungs, methotrexate and psoriasis

Gohar, A

doi:10.1111/ced.13977

Search citation statements

Order By: Relevance

Paper Sections

Select...

Introduction1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2019

2023

Publication Types

Select...

Article3

Relationship

Self Cite1

Independent2

Authors

Journals

Cited by 3 publications

(2 citation statements)

References 8 publications

(10 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…5,6 Although MTX has a wide dosage administration range, low-dose MTX has side effects, while high-dose MTX even poses life-threatening side effects. [7][8][9][10] In addition, the total body clearance (40-400 mL min −1 ) of MTX is highly variable due to the metabolism differences between individuals. Measuring MTX in patient blood samples is believed to be important for safe medication and personalized medicine.…”

Section: Introductionmentioning

confidence: 99%

Ultrasensitive therapeutic drug monitoring of methotrexate by a structure-switching aptamer with cascade primer exchange reaction

He¹,

Wang²,

Zhang³

et al. 2023

Analyst

View full text Add to dashboard Cite

show abstract

Section: Introductionmentioning

confidence: 99%

Ultrasensitive therapeutic drug monitoring of methotrexate by a structure-switching aptamer with cascade primer exchange reaction

He¹,

Wang²,

Zhang³

et al. 2023

Analyst

View full text Add to dashboard Cite

show abstract

“…We thank Dr Gohar for his recent letter to Clinical and Experimental Dermatology , and his interest in our case report and discussion . Pulmonary fibrosis arising in association with methotrexate (MTX) therapy was first reported in the 1970s in the context of cancer chemotherapy with very high doses (up to 3.5 g/m 2 ).…”

mentioning

confidence: 99%